CET and skills guides

Study and gain CET points through OT’s online CET exams, and access archived CET, CPD articles and skills guides in our education library

Find out more

Science and vision

News and features about the latest scientific developments and advances in optometry, ophthalmology and eye medicine

Find out more

Professional support

News and features about the latest developments relating to professional support from across optics. This includes updates from optical organisations such as the AOP and the GOC

Find out more

In practice

News and in-depth features about business management and career development in optics

Find out more


Explore the latest UK and global jobs in the optical sector for optometrists, dispensing opticians and more

Find out more

Appointing Dr Jones

The director of CORE has joined the TFOS board of directors


The director of the Centre for Ocular Research & Education (CORE, formerly CCLR) at the University of Waterloo’s school of optometry and vision science, Dr Lyndon Jones, has been appointed to the Tear Film & Ocular Surface Society’s (TFOS) board of directors.

Dr Jones was involved with the TFOS DEWS II report, with a seat on the harmonisation committee and chair of the management and therapy sub-committee.

In addition to his role as director of CORE, Dr Jones is a professor and research chair at the Canadian university.

Speaking about his appointment, Dr Jones said it was “an honour to join the TFOS board of directors and humbling to serve alongside some of the most brilliant minds in our field.”

“The work of this organisation has been instrumental in advancing not only research regarding the ocular surface, but its application in clinical settings, creating meaningful benefits for scientists, eye care professionals and patients alike,” he added.

Dr Jones’ research interests focus on the interaction of novel and existing contact lens materials with the ocular environment, dry eye and the development of novel materials for ocular drug delivery.

TFOS executive director, Amy Gallant Sullivan, said: “We look forward to leveraging Lyndon’s energy, deep subject matter expertise, and track record of ground breaking collaboration with the most prominent and insightful members of the ocular science and clinical communities.”